BMP4 and acute lymphoblastic leukemia: Additionally, our results showed no changes in the expression of different BMP4 antagonists in ALL-MSCs compared to Healthy-MSCs, except in the MSCs isolated from BM out of therapy, which exhibited significantly higher Noggin expression than any other MSC groups, including healthy controls (Fig. 5D).